Koichi Onodera

549 citations
38 papers · 264 indexed · h-index 11
Topics
Viral-associated cancers and disorders (8 papers)Lymphoma Diagnosis and Treatment (7 papers)Chronic Lymphocytic Leukemia Research (5 papers)

In The Last Decade

Koichi Onodera

28 papers receiving 262 citations

Peers

Koichi Onodera
Comparison fields: 5 of 59
  • Hematology 79
  • Oncology 67
  • Genetics 64
  • Molecular Biology 63
  • Immunology 40
Replace Manfred Ahlgrimm with:
Manfred Ahlgrimm Germany
Siyang Leng United States
Kristina Sohlbach Germany
Marta Sonia González Spain
Maria Luigia Vigliotti Italy
Claudia I. Chapuy United States
Nita Williams United States
Pasquale L. Fedele Australia
Audrey Turchick United States
Danielle Shafer United States
Koichi Onodera relative to Manfred Ahlgrimm Germany Manfred Ahlgrimm's profile →
Citations per field
00.5×4.9×
Manfred Ahlgrimm · 1×
Citations per year

Countries citing papers authored by Koichi Onodera

Since Specialization
Citations

This map shows the geographic impact of Koichi Onodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Onodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Onodera more than expected).

Fields of papers citing papers by Koichi Onodera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Onodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Onodera. The network helps show where Koichi Onodera may publish in the future.

Co-authorship network of co-authors of Koichi Onodera

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Onodera. A scholar is included among the top collaborators of Koichi Onodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Onodera. Koichi Onodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 1
5 0
6 0
7 0
8 2
9 0
10 14
11 0
12 13
13 1
14 0
15 8
16 1
17 1
18 13
19 4
20 13

About Koichi Onodera

Koichi Onodera is a scholar working on Hematology, Genetics and Oncology, having authored 38 papers that have together received 264 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (79 citations), Genetics (64 citations) and Oncology (67 citations). Koichi Onodera has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Noriko Fukuhara, Yasushi Onishi, Hideo Harigae, Tohru Fujiwara, Satoshi Ichikawa, Hisayuki Yokoyama, Masamitsu Hatakenaka, Yoko Okitsu, Ritsuko Shimizu and Masayuki Yamamoto. Their work appears in journals such as New England Journal of Medicine, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026